胆红素通过Akt-mTOR信号通路影响微质自
Ling Li1,2,3, Siyu Li1,2,3, Zhifan Pan2,3
1Department of Neonatology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
Journal of neurochemistry
|October 20, 2023
概括
非结合性胆红素通过Akt-mTOR途径损害微质自,在胆红素脑病变中恶化神经炎症. 增强自可能为这种疾病提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 胆红素脑病变是一种严重的新生儿并发症,涉及神经炎症.
- 微质自在这种情况中的作用尚不清楚.
- 自越来越多地被认为是其在炎症反应中的作用.
研究的目的:
- 为了研究非结合性胆红素 (UCB) 对微质自的作用.
- 阐明UCB诱导的神经炎症的潜在分子机制.
- 探索调节微质自的治疗潜力.
主要方法:
- 主要培养的微细胞被用UCB治疗.
- 分析了自标记物 (LC3B-II/I,ATG蛋白,p62) 和信号通路 (TLR4,Akt,mTOR) 的情况.
- 拉巴胺素 (mTOR抑制剂) 用于促进自.
- 评估了炎症酶组分 (NLRP3) 和IL-1β.
主要成果:
- 通过降低LC3B-II/I比率和关键ATG蛋白,UCB损害了微质自,同时增加了p62.
- UCB提高了TLR4的调节,并激活了Akt-mTOR通路.
- 拉巴胺治疗增强了自,减少了NLRP3炎症酶激活,并减轻了神经炎症.
- 由UCB诱导的自功能障碍与神经炎症有关.
结论:
- 通过Akt-mTOR通路,UCB抑制了微质自,加剧了神经炎症.
- 调节微质自,可能通过mTOR抑制,可能是胆红素脑病变的治疗策略.
- 向微质自可能会破坏NLRP3炎症酶组合并改善结果.
相关概念视频
Autophagy
4.3K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K


